Tel:
Email:

Bevasiranib sodium - CAS 849758-52-7

Catalog number: BRP-02088

Bevasiranib sodium

Bevasiranib sodium is a small interfering RNA (siRNA) therapeutic designed to treat ocular diseases, particularly age-related macular degeneration (AMD). By targeting and silencing the mRNA for vascular endothelial growth factor (VEGF), bevasiranib sodium aims to inhibit the production of VEGF, a key protein involved in the formation of abnormal blood vessels and increased vascular permeability in the retina, which are characteristic of AMD.

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
Catalog
BRP-02088
Synonyms
RNA, (A-C-C-U-C-A-C-C-A-A-G-G-C-C-A-G-C-A-C-dT-dT), eicosasodium salt, complex with RNA (G-U-G-C-U-G-G-C-C-U-U-G-G-U-G-A-G-G-U-dT-dT) eicosasodium salt (1:1); Cand 5
CAS
849758-52-7
Storage
Store at -20 °C
Sequence
RNA, (accucaccaaggccagcactt), complex with RNA (gugcuggccuuggugaggutt) (1:1), sodium salt
Related CAS
959961-96-7 (free acid)

Chemical Structure:


Our Products

BOC Sciences is a leading provider of DNA and RNA products and services that meet the needs of researchers and pharmaceutical companies worldwide. Its broad product portfolio includes various types of oligonucleotides, DNA/RNA synthesis feedstocks, RNA interference tools, and advanced drug delivery systems, among others. Designed to promote cutting-edge research and innovative therapeutic solutions, at BOC Sciences you are sure to find the right product for you.

Online Inquiry
Verification code
Inquiry Basket